4//SEC Filing
Farzan Nima 4
Accession 0001209191-21-010892
CIK 0001797768other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 5:54 PM ET
Size
5.4 KB
Accession
0001209191-21-010892
Insider Transaction Report
Form 4
Farzan Nima
DirectorPresident and CEO
Transactions
- Award
Employee stock option (right to buy)
2021-02-12+275,000→ 275,000 totalExercise: $35.38Exp: 2031-02-12→ Common Stock (275,000 underlying)
Footnotes (1)
- [F1]The Option vests and becomes exercisable over time at the following rate: 1/48th of the total number of shares subject to the Option shall vest each month in equal installments starting on March 1, 2021.
Documents
Issuer
Kinnate Biopharma Inc.
CIK 0001797768
Entity typeother
Related Parties
1- filerCIK 0001808296
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 5:54 PM ET
- Size
- 5.4 KB